(Total Views: 327)
Posted On: 05/21/2018 1:02:13 PM
Post# of 72446
Acne Vulgaris
Spanning over 182 pages “Acne Vulgaris – Pipeline Review, H1 2018” report covers Introduction, Acne Vulgaris – Overview, Acne Vulgaris – Therapeutics Development, Acne Vulgaris – Therapeutics Assessment, Acne Vulgaris – Companies Involved in Therapeutics Development, Acne Vulgaris – Drug Profiles, Acne Vulgaris – Dormant Projects, Appendix. This report Covered Companies – 3SBio Inc, BioPharmX Inc, Braintree Laboratories Inc, Cassiopea SpA, Cutanea Life Sciences Inc, Daewoong Co Ltd, Deltanoid Pharmaceuticals Inc, ELORAC Inc, Foamix Pharmaceuticals Ltd, Galderma SA, Helix BioMedix Inc, Innovation Pharmaceuticals Inc, Lee's Pharmaceutical Holdings Ltd, LEO Pharma A/S, Melinta Therapeutics Inc.
Spanning over 182 pages “Acne Vulgaris – Pipeline Review, H1 2018” report covers Introduction, Acne Vulgaris – Overview, Acne Vulgaris – Therapeutics Development, Acne Vulgaris – Therapeutics Assessment, Acne Vulgaris – Companies Involved in Therapeutics Development, Acne Vulgaris – Drug Profiles, Acne Vulgaris – Dormant Projects, Appendix. This report Covered Companies – 3SBio Inc, BioPharmX Inc, Braintree Laboratories Inc, Cassiopea SpA, Cutanea Life Sciences Inc, Daewoong Co Ltd, Deltanoid Pharmaceuticals Inc, ELORAC Inc, Foamix Pharmaceuticals Ltd, Galderma SA, Helix BioMedix Inc, Innovation Pharmaceuticals Inc, Lee's Pharmaceutical Holdings Ltd, LEO Pharma A/S, Melinta Therapeutics Inc.
(0)
(0)
